IP Library Granted Patent US 11,560,593
Granted Patent B2
US 11,560,593 · App. 17/707,189 · Granted Jan 24, 2023

Methods for spatial analysis using RNA-templated ligation

Inventors: James Michael Chell (Stockholm, SE); Marlon Stoeckius (Stockholm, SE); Jonathan Alles (Berlin, DE); Caroline Julie Gallant (Stockholm, SE); Christina Galonska (Stockholm, SE); Felice Alessio Bava (Pleasanton, CA); Layla Katiraee (Pleasanton, CA)
Assignee: 10x Genomics, Inc.
C12Q1/6876C12Q1/25C12Q1/6811C12Q1/6816C12Q1/6841C12Q1/6851
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,560,593
App. No.
17/707,189
Granted
Jan 24, 2023
Kind
B2
Abstract

Provided herein are methods of detecting an analyte of interest to interrogate spatial gene expression in a sample using RNA-templated ligation.

Claims (59)

1. A method for determining a location of a target nucleic acid in a biological sample comprising:

(a) providing an array comprising a plurality of capture probes affixed to the array, wherein a capture probe comprises: (i) a spatial barcode and (ii) a capture domain;

(b) contacting a plurality of first probes and second probes to a biological sample on the array, wherein the first probes and second probes target a plurality of nucleic acids in the biological sample,

wherein a first probe comprises a first sequence that is substantially complementary to a first target sequence of the target nucleic acid;

wherein a second probe comprises:

a second sequence that is substantially complementary to a second target sequence of the target nucleic acid;

a third sequence that is substantially complementary to a third target sequence of the target nucleic acid; and

wherein the first probe or the second probe comprises a capture probe capture domain that is complementary to all or a portion of the capture domain of the capture probes affixed to the array;

(c) hybridizing the first probe to the first sequence and the second probe to the second sequence and the third sequence;

(d) generating a ligation product by ligating the first probe and the second probe;

(e) hybridizing the ligation product to the capture domain of the capture probe; and

(f) determining (i) all or part of the sequence of the ligation product hybridized to the capture domain, or a complement thereof, and (ii) the sequence of the spatial barcode, or a complement thereof, and using the determined sequences of (i) and (ii) to determine the location of the target nucleic acid in the biological sample.

2. The method of claim 1 , wherein the second target sequence and the third target sequence are on different exons of the target nucleic acid.

3. The method of claim 1 , wherein the second target sequence and the third target sequence are located within the same exon of the target nucleic acid but are not adjacent on the target nucleic acid.

4. The method of claim 1 , wherein the second probe further comprises a linker sequence between the second sequence and the third sequence, wherein the linker sequence is about 1 nucleotide to about 100 nucleotides in length.

5. The method of claim 4 , wherein the linker sequence comprises a barcode sequence that serves as a proxy for identifying the target nucleic acid.

6. The method of claim 1 , wherein the first probe and the second probe are substantially complementary to adjacent sequences of the target nucleic acid.

7. The method of claim 1 , where the first probe and the second probe hybridize to sequences that are not adjacent to each other on the target nucleic acid.

8. The method of claim 7 , wherein the first probe is extended with a DNA polymerase, thereby (i) filling in a gap between the first probe and the second probe and (ii) generating an extended first probe.

9. The method of claim 1 , wherein the contacting the first probe and the second probe with the biological sample comprises contacting the biological sample with 5000 or more probe pairs comprising the first probe and the second probe.

10. The method of claim 1 , wherein the contacting the first probe and the second probe with the biological sample comprises contacting the biological sample with 100 or more probe pairs comprising the first probe and the second probe.

11. The method of claim 1 , wherein the generating the ligation product comprises ligating the first probe to the second probe using enzymatic ligation or chemical ligation, wherein the enzymatic ligation utilizes a ligase.

12. The method of claim 11 , wherein the ligase is one or more of a T4 RNA ligase (Rnl2), a PBCV-1 ligase, a single stranded DNA ligase, or a T4 DNA ligase.

13. The method of claim 1 , wherein the first probe or the second probe further comprises a primer sequence.

14. The method of claim 1 , further comprising providing a capture probe capture domain blocking moiety that interacts with the capture probe capture domain sequence.

15. The method of claim 14 , further comprising releasing the capture probe capture domain blocking moiety from the capture probe capture domain sequence prior to step (e).

16. The method of claim 1 , wherein the first probe and/or the second probe is a DNA probe.

17. The method of claim 1 , wherein step (d) further comprises releasing the ligation product from the target nucleic acid, wherein releasing comprises contacting the biological sample with an endoribonuclease.

18. The method of claim 17 , wherein the endoribonuclease is an RNase H enzyme.

19. The method of claim 1 , wherein the biological sample is a formalin-fixed, paraffin-embedded tissue sample, a fresh tissue sample, or a frozen tissue sample.

20. The method of claim 1 , wherein the biological sample is a formalin-fixed, paraffin-embedded tissue sample.

21. The method of claim 1 , wherein the biological sample was previously stained using immunofluorescence, immunohistochemistry, or hematoxylin and eosin.

22. The method of claim 1 , further comprising contacting the biological sample with a permeabilization agent, wherein the permeabilization agent comprises proteinase K or pepsin.

23. The method of claim 1 , wherein the target nucleic acid comprises RNA.

24. The method of claim 23 , wherein the RNA is an mRNA.

25. The method of claim 1 , wherein the determining step (f) comprises amplifying all or part of the ligation product, thereby generating an amplified product, and wherein the amplified product comprises (i) all or part of the sequence of the ligation product, or a complement thereof, and (ii) the sequence of the spatial barcode, or a complement thereof.

26. The method of claim 1 , wherein the determining step (f) comprises sequencing (i) all or a part of the sequence of the ligation product, or a complement thereof, and (ii) the sequence of the spatial barcode, or a complement thereof.

27. The method of claim 26 , wherein the sequencing comprises in situ sequencing, Sanger sequencing methods, and next-generation sequencing methods.

28. A kit for determining a location of a target nucleic acid in a biological sample, the kit comprising:

(a) an array comprising a plurality of capture probes affixed to the array, wherein a capture probe comprises a spatial barcode and a capture domain, wherein the spatial barcode comprises a sequence that provides a location of an analyte in a biological sample;

(b) a first probe and a second probe,

wherein the first probe comprises a first sequence that is substantially complementary to a first target sequence of the target nucleic acid,

wherein a second probe comprises:

a second sequence that is substantially complementary to a second target sequence of the target nucleic acid,

a third sequence that is substantially complementary to a third target sequence of the target nucleic acid, and

wherein the first probe or the second probe comprises a capture probe capture domain sequence that is complementary to all or a portion of the capture domain of the capture probes affixed to the array;

(c) an RNAse; and

(d) instructions for performing the method of claim 2 .

29. The kit of claim 28 , further comprising a ligase.

30. A kit for determining a location of a target nucleic acid in a biological sample, the kit comprising:

(a) an array comprising a plurality of capture probes affixed to the array, wherein a capture probe comprises a spatial barcode and a capture domain, wherein the spatial barcode comprises a sequence that provides a location of an analyte in a biological sample;

(b) a first probe and a second probe, wherein the first probe and the second probe each comprise one or more sequences that are substantially complementary to sequences of the analyte, and wherein one of the first probe or the second probe comprises a capture probe capture domain that is substantially complementary to the capture domain of the capture probe on the array; and

(c) instructions for performing a method for determining a location of the target nucleic acid in a biological sample, the method comprising:

(A) providing the array;

(B) contacting a plurality of first probes and second probes to a biological sample on the array;

(C) hybridizing the first probe and the second probe to the target nucleic acid;

(D) generating a ligation product by ligating the first probe and the second probe;

(E) hybridizing the ligation product to the capture domain of the capture probe affixed on the array; and

(G) determining (i) all or part of the sequence of the ligation product hybridized to the capture domain, or a complement thereof, and (ii) the sequence of the spatial barcode, or a complement thereof, and using the determined sequences of (i) and (ii) to determine the location of the target nucleic acid in the biological sample.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2022
From: CHELL, JAMES MICHAEL; STOECKIUS, MARLON; ALLES, JONATHAN; GALLANT, CAROLINE JULIE; GALONSKA, CHRISTINA
To: SPATIAL TRANSCRIPTOMICS AB
Reel/Frame 059832/0764 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2022
From: BAVA, FELICE ALESSIO; KATIRAEE, LAYLA
To: 10X GENOMICS, INC.
Reel/Frame 059832/0843 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2022
From: SPATIAL TRANSCRIPTOMICS AB
To: 10X GENOMICS, INC.
Reel/Frame 059832/0880 →
Continuity (7)
Continuation 17220529 · Apr 1, 2021
Continuation PCTUS2020066720 · Dec 22, 2020
Provisional Application 63108088 · Oct 30, 2020
Provisional Application 63087061 · Oct 2, 2020
Provisional Application 62969458 · Feb 3, 2020
Provisional Application 62952736 · Dec 23, 2019
Related Publication 20220282329A1 · Sep 8, 2022
Cited By (42)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,234,505 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,297,487 US 12,297,488 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,391,979 US 12,391,980 US 12,399,123 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,497,654 US 12,508,590 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,571,029 US 12,624,475 US 12,637,706 US 12,692,492